Herbas VPB

Print
EN | LT
LT - Biciklinio sulieto heteroarilo arba arilo junginiai ir jų naudojimas kaip IRAK4 inhibitorių
EN - BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 207/00 (2006.01)
C07D 215/48 (2006.01)
C07D 217/00 (2006.01)
C07D 239/00 (2006.01)
C07D 263/24 (2006.01)
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
A61K 31/47 (2006.01)
A61K 31/4709 (2006.01)
A61K 31/472 (2006.01)
A61K 31/4725 (2006.01)
A61K 31/517 (2006.01)
A61P 11/06 (2006.01)
A61P 13/12 (2006.01)
A61P 17/06 (2006.01)
A61P 19/02 (2006.01)
A61P 29/00 (2006.01)
European patent
(11) Number of the document 3536685
(13) Kind of document T
(96) European patent application number 19157789.9
Date of filing the European patent application 2015-03-26
(97) Date of publication of the European application 2019-09-11
(45) Date of publication and mention of the grant of the patent 2022-02-16
(46) Date of publication of the claims translation 2022-04-25
Priority applications
(30) Number Date Country code
201461975473 P 2014-04-04 US
Inventors
(72)
ANDERSON, David Randolph , US
BUNNAGE, Mark Edward , US
CURRAN, Kevin Joseph , US
DEHNHARDT, Christoph Martin , CA
GAVRIN, Lori Krim , US
GOLDBERG, Joel Adam , US
HAN, Seungil , US
HEPWORTH, David , US
HUANG, Horng-Chih , US
LEE, Arthur , US
LEE, Katherine Lin , US
LOVERING, Frank Eldridge , US
LOWE, Michael Dennis , US
MATHIAS, John Paul , US
PAPAIOANNOU, Nikolaos , US
PATNY, Akshay , US
PIERCE, Betsy Susan , US
SAIAH, Eddine , US
STROHBACH, Joseph Walter , US
TRZUPEK, John David , US
VARGAS, Richard , US
WANG, Xiaolun , US
WRIGHT, Stephen Wayne , US
ZAPF, Christoph Wolfgang , US
Grantee
(73) Pfizer Inc., 66 Hudson Boulevard East, New York, NY 10001-2192, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Biciklinio sulieto heteroarilo arba arilo junginiai ir jų naudojimas kaip IRAK4 inhibitorių
  BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS
Last renewal fee
Payment date Validity (years) Amount
2024-02-09 10 231.00 EUR
Next renewal fee
2025-03-26